IP Library Granted Patent US 7,537,751
Granted Patent B2
US 7,537,751 · App. 10/763,088 · Granted May 26, 2009

Labeling reagents and labeled targets comprising nonmetallic porphyrins

Assignee: Enzo Life Science, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,537,751
App. No.
10/763,088
Granted
May 26, 2009
Kind
B2
Abstract

This invention provides for labeling reagents, labeled targets and processes for preparing labeling reagents. The labeling reagents can take the form of cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes. These labeling reagents are useful for labeling probes or targets, including nucleic acids and proteins. These reagents can be usefully applied to protein and nucleic acid probe based assays. They are also applicable to real-time detection processes.

Claims (15)

1. A labeling reagent comprising a nonmetallic porphyrin, said reagent comprising:

wherein R 0 is a reactive group and is attached directly or indirectly to any one of the four non-pyrrole positions of said nonmetallic porphyrin, and R 1 through R 8 independently comprise hydrogen, aliphatic, unsaturated aliphatic, cyclic, heterocyclic, aromatic, heteroaromatic, charged or polar groups, or any combinations of the foregoing, wherein said reactive group R 0 comprises sulfhydryl, hydroxyl, amine, isothiocyanate, isocyanate, monochlorotriazine, dichlorotriazine, mono- or di-halogen substituted pyridine, mono- or di-halogen substituted diazine, maleimide, aziridine, sulfonylhalide, acid halide, hydroxysuccinimide ester, hydroxysulfosuccinimide ester, imidoester, hydrazine, azidonitrophenyl, azide, 3-(2-pyridyldithio)-proprionamide, glyoxal, an alkene group, an alkyne group or a halogenated compound.

2. The labeling reagent of claim 1 , wherein any of said R 1 through R 8 alkyl groups comprises methyl, ethyl or propyl.

3. The labeling reagent of claim 1 , wherein any of said R 1 through R 8 alkyl groups further comprises a polar or charged group.

4. A labeling reagent comprising a nonmetallic porphyrin, said reagent comprising:

wherein R 0 is a reactive group and is attached directly or indirectly to any one of the four non-pyrrole positions of said nonmetallic porphyrin, and R 1 through R 8 independently comprise hydrogen, aliphatic, unsaturated aliphatic, cyclic, heterocyclic, aromatic, heteroaromatic, charged or polar groups, or any combinations of the foregoing, wherein said reactive group R 0 comprises sulfhydryl, hydroxyl, amine, isothiocyanate, isocyanate, monochlorotriazine, dichlorotriazine, mono- or di-halogen substituted pyridine, mono- or di-halogen substituted diazine, maleimide, aziridine, sulfonylhalide, acid halide, hydroxysuccinimide ester, hydroxysulfosuccinimide ester, imidoester, hydrazine, azidonitrophenyl, azide, 3-(2-pyridyldithio)-proprionamide, glyoxal, aldehyde, or a moiety capable of forming a carbon-carbon linkage with a target wherein said moiety is an alkene group, an alkyne group or a halogenated compound, and wherein said reactive group R 0 is attached indirectly to said nonmetallic porphyrin through a linker arm.

5. A labeling reagent comprising a nonmetallic porphyrin, said reagent comprising:

wherein R 0 is a reactive group and is attached directly or indirectly to any one of the four non-pyrrole positions of said nonmetallic porphyrin, and R 1 through R 8 independently comprise hydrogen, aliphatic, unsaturated aliphatic, cyclic, heterocyclic, aromatic, heteroaromatic, charged or polar groups, or any combinations of the foregoing, wherein said reactive group R 0 comprises sulfhydryl, hydroxyl, amine, isothiocyanate, isocyanate, monochlorotriazine, dichlorotriazine, mono- or di-halogen substituted pyridine, mono- or di-halogen substituted diazine, maleimide, aziridine, sulfonylhalide, acid halide, hydroxysuccinimide ester, hydroxysulfosuccinimide ester, imidoester, hydrazine, azidonitrophenyl, azide, 3 -(2-pyridyldithio)-proprionamide, glyoxal, aldehyde, or a moiety capable of forming a carbon-carbon linkage with a target wherein said moiety is an alkene group, an alkyne group or a halogenated compound, wherein said reactive group R 0 is attached indirectly to said non-metallic porphyrin through a linker arm and said linker arm comprises at least two consecutive peptide bonds.

6. A labeled target comprising a nonmetallic porphyrin, said reagent comprising:

wherein T is a target molecule attached directly or indirectly to any one of the four non-pyrrole positions of said nonmetallic porphyrin and R 1 through R 8 independently comprise hydrogen, aliphatic, unsaturated aliphatic, cyclic, heterocyclic, aromatic, heteroaromatic, charged or polar groups, or any combinations of the foregoing, wherein said target T comprises a nucleic acid, a nucleotide or a nucleic analog, a receptor, a hormone, a lymphokine, a cytokine, a toxin, a carbohydrate, a sugar or an oligo- or polysaccharide.

7. The labeled target of claim 6 , wherein said nucleic acid or nucleotide or nucleotide analog is modified.

8. The labeling reagent of claim 6 , wherein any of said R 1 through R 8 alkyl groups comprises methyl, ethyl or propyl.

9. The labeling reagent of claim 6 , wherein any of said R 1 through R 8 alkyl groups further comprises a polar or charged group.

10. The labeling reagent of claim 6 , wherein said target T is attached indirectly to said nonmetallic porphyrin through a linker arm.

11. The labeling reagent of claim 10 , wherein said linker arm comprises at least two consecutive peptide bonds.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jul 24, 2023
From: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
To: ENZO BIOCHEM, INC.; ENZO CLINICAL LABS, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP; ENZO LIFE SCIENCES, INC.
Reel/Frame 064369/0031 →
SECURITY INTEREST Recorded Apr 3, 2023
From: ENZO LIFE SCIENCES, INC.; ENZO CLINICAL LABS, INC.; ENZO BIOCHEM, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP
To: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
Reel/Frame 063239/0103 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2015
From: STAVRIANOPOULOS, JANNIS G.; RABBANI, ELAZAR
To: ENZO LIFE SCIENCES, INC.
Reel/Frame 036771/0058 →
Continuity (2)
Division 1009607500 · Mar 12, 2002
Related Publication 20060172308A1 · Aug 3, 2006